OMEROS CORP Cost of Goods Sold (Deprecated 2018-01-31)
OMEROS CORP (OMER) reported Cost of Goods Sold (Deprecated 2018-01-31) of $116.00 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-08-09
- OMEROS CORP cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $116.00K, a 26.11% decline year-over-year.
- OMEROS CORP cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $203.00K, a 25.09% decline year-over-year.
- OMEROS CORP cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $465.00K, a 22.37% increase year-over-year.
- OMEROS CORP cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $184.00K, a 51.32% decline year-over-year.
- OMEROS CORP cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $1.08M, a 23.65% decline from fiscal 2016.
- OMEROS CORP cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $1.41M, a 35.64% increase from fiscal 2015.
- OMEROS CORP cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $1.04M.
- OMEROS CORP cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $0.00.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-06-30 | $116.00K 10-Q · filed 2018-08-09 | $319.00K 10-Q · filed 2018-08-09 | $784.00K derived: sum of 3 quarters · filed 2018-08-09 | $968.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | $203.00K 10-Q · filed 2018-05-10 | $668.00K derived: sum of 2 quarters · filed 2018-05-10 | $852.00K derived: sum of 3 quarters · filed 2018-05-10 | $1.01M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-12-31 | $465.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $649.00K derived: sum of 2 quarters · filed 2018-03-01 | $806.00K derived: sum of 3 quarters · filed 2018-08-09 | $1.08M 10-K · filed 2018-03-01 |
| 2017-09-30 | $184.00K 10-Q · filed 2017-11-09 | $341.00K derived: sum of 2 quarters · filed 2018-08-09 | $613.00K 10-Q · filed 2017-11-09 | $992.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-06-30 | $157.00K 10-Q · filed 2018-08-09 | $429.00K 10-Q · filed 2018-08-09 | $808.00K derived: sum of 3 quarters · filed 2018-08-09 | $1.19M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $271.00K 10-Q · filed 2018-05-10 | $651.00K derived: sum of 2 quarters · filed 2018-05-10 | $1.03M derived: sum of 3 quarters · filed 2018-05-10 | $1.36M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $380.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $758.00K derived: sum of 2 quarters · filed 2018-03-01 | $1.08M derived: sum of 3 quarters · filed 2018-03-01 | $1.41M 10-K · filed 2018-03-01 |
| 2016-09-30 | $378.00K 10-Q · filed 2017-11-09 | $705.00K derived: sum of 2 quarters · filed 2017-11-09 | $1.03M 10-Q · filed 2017-11-09 | $1.45M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $327.00K 10-Q · filed 2017-08-08 | $654.00K 10-Q · filed 2017-08-08 | $1.07M derived: sum of 3 quarters · filed 2018-03-01 | $1.32M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $327.00K 10-Q · filed 2017-05-10 | $744.00K derived: sum of 2 quarters · filed 2018-03-01 | $992.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.36M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $665.00K derived: sum of 2 quarters · filed 2018-03-01 | $1.03M derived: sum of 3 quarters · filed 2018-03-01 | $1.04M 10-K · filed 2018-03-01 |
| 2015-09-30 | $248.00K 10-Q · filed 2016-11-09 | $613.00K derived: sum of 2 quarters · filed 2016-11-09 | $624.00K 10-Q · filed 2016-11-09 | $624.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $365.00K 10-Q · filed 2016-08-09 | $376.00K 10-Q · filed 2016-08-09 | $376.00K derived: sum of 3 quarters · filed 2017-03-16 | $376.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $11.00K 10-Q · filed 2016-05-10 | $11.00K derived: sum of 2 quarters · filed 2017-03-16 | $11.00K derived: sum of 3 quarters · filed 2017-03-16 | $11.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $0.00 10-K · filed 2017-03-16 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |